Max Davidson

Max Davidson is a highly experienced Research Scientist with a robust background in proteomics and cell biology, currently working at Oblique Therapeutics since November 2015. Previous roles include positions at Nanoxis Consulting AB and Nanoxis AB, where responsibilities encompassed culturing and characterizing cell lines, subcellular fractionation, and mass spectrometry sample preparation. Max's research has focused on strain-level discrimination of bacteria, including E. coli and H. Pylori, utilizing advanced analytical techniques. Prior to entering the industry, Max held a position as a System Developer at Sahlgrenska University Hospital, where bacterial proteomics data were analyzed. Max holds a PhD in Chemistry and a Master’s Degree in Chemistry from the University of Gothenburg, complemented by studies in the Biomedical Research School.